Most Down Articles

Published in last 1 year | In last 2 years| In last 3 years| All| Most Downloaded in Recent Month | Most Downloaded in Recent Year|

Most Downloaded in Recent Year

Please wait a minute...


For Selected: Download Citations EndNote Ris BibTeX Toggle Thumbnails

Select

China Journal of Oral and Maxillofacial Surgery    2012, 10 (5): 417-422.   Abstract （587）      PDF （1339KB）（13103）       Knowledge map    Related Articles | Metrics

Select

Expert consensus on diagnosis and clinical management of medication-related osteonecrosis of the jaw HE Yue, CHEN Heng, AN Jin-gang, GUO Yu-xing, PAN Jian, TIAN Lei, LIU Bing, HOU Jin-song, LI Jin-song, JIANG Can-hua, LI Meng-yu, TIAN Zhen, XU Jie, ZHU Ling, SUN Chang-fu, ZHI Ke-qian, QU Qing, ZONG Chun-lin, SUN Jing-jing, ZHANG Zhi-yuan China Journal of Oral and Maxillofacial Surgery    2023, 21 (4): 313-325.   DOI: 10.19438/j.cjoms.2023.04.001 Abstract （1169）      PDF （2051KB）（1409）       Knowledge map    Medication-related osteonecrosis of the jaw(MRONJ) is a complication caused by the application of anti-resorptive medications, angiogenesis inhibitors, hormones and other medications for the treatment of some systemic diseases. The clinical symptoms include swelling, pain, masticatory disorders, persistent fistula, bone exposure and even pathological fracture, which seriously affect the patients' quality of life. Domestically, there is a lack of consensus or guidelines on classification, staging and treatment of MRONJ, and different institutions make diagnosis and treatment plans empirically. In order to unify and standardize the diagnosis and treatment of MRONJ and improve the prognosis, an expert panel of MRONJ research from 12 famous domestic medical colleges and affiliated hospitals convened a meeting to discuss the diagnosis and treatment opinions of MRONJ. Meanwhile, consensus recommendations were also revised with a comprehensive literature review of the previous treatment experiences and research findings. Finally, this expert consensus was finished for clinical references. Reference | Related Articles | Metrics

Select

Chinese experts consensus on the use of oral propranolol for treatment of infantile hemangiomas(version 2022) ZHENG Jia-wei, WANG Xu-kai, QIN Zhong-ping, FAN Xin-dong, LI Kai, YANG Yao-wu, HUO Ran, LIU Shao-hua, ZHAO Ji-hong, WANG Xiao-yong, ZHOU De-kai, LIU Xue-jian China Journal of Oral and Maxillofacial Surgery    2022, 20 (4): 313-319.   DOI: 10.19438/j.cjoms.2022.04.001 Abstract （1305）      PDF （1061KB）（1201）       Knowledge map    Since 2008, propranolol has become the first-line treatment for infantile hemangiomas. Many researches have been reported on its treatment mechanism both at home and abroad, and several expert consensus or clinical practice guidelines have been formulated and published. In recent years, with the continuous accumulation of clinical experience, increasing number of basic research works, and deepening understanding of the pathogenesis of hemangioma and the mechanism of action of propranolol, it is necessary to update the expert consensus to be more consistent with clinical practice, in order to guide medication and management, provide scientific norms for the clinical use of propranolol in the treatment of infantile hemangiomas. This updated version mainly simplified the process of clinical examination, medication, and monitoring, making it more convenient and operable. Reference | Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2007, 5 (2): 83-90.   Abstract （2078）      PDF （1354KB）（4384）       Knowledge map    Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2009, 7 (1): 84-87.   Abstract （344）      PDF （813KB）（837）       Knowledge map    Related Articles | Metrics

Select

Expert consensus on surgical treatment of hemangiomas and vascular malformations in the head and neck WANG Yan-an, QIN Zhong-ping, ZHENG Jia-wei, LI Chun-jie, LIU Shao-hua, YANG Yao-wu, CHEN Gang, CHEN Wei-liang, LIU Xue-jian, DU Zhong, ZHANG Lei, WANG Ye-fei, WANG De-ming, SU Li-xin, XIE Feng, DONG Chang-xian, GUO Lei, LI Kai, GU Song, HE Yue, ZHANG Zhi-yuan China Journal of Oral and Maxillofacial Surgery    2024, 22 (2): 105-117.   DOI: 10.19438/j.cjoms.2024.02.001 Abstract （500）      PDF （2515KB）（510）       Knowledge map    Hemangiomas and vascular malformations are common benign vascular diseases in the head and neck region. The evolution and extensive implementation of non-surgical therapeutic modalities have resulted in considerable improvement or even total remission in a significant number of patients in minimally invasive or non-invasive procedures. Nonetheless, under certain circumstances, surgical treatment remains an irreplaceable treatment modality within the comprehensive treatment sequence for hemangiomas and vascular malformations in the head and neck. However, there is no established standard or consensus in the academic community on how to choose and apply surgical treatment. Therefore, to enhance the treatment efficacy of hemangiomas and vascular malformations amongst domestic peers, and to standardize surgical treatment protocols, this consensus brings together the discussion opinions of relevant experts from many medical schools and affiliated hospitals nationwide. Based on the latest domestic and international research results and diagnosis and treatment experience, we formulated this expert consensus from the aspects of preoperative diagnosis and preparation, surgical treatment indications and strategies, postoperative care and observation, common complications and treatment after surgery, follow-up and social psychological support. It is expected to be used in clinical practice and to guide relevant professional doctors carrying out treatment. Reference | Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2017, 15 (2): 185-188.   DOI: 10.19438/j.cjoms.2017.02.018 Abstract （393）      PDF （2529KB）（1211）       Knowledge map    Reference | Related Articles | Metrics

Select

Chinese Expert consensus on the diagnosis, treatment of odontogenic keratocyst LIU Bing, HE Yue, PENG Xin, SUN Chang-fu, HAN Zheng-xue, WU Yu-nong, PENG Li-wei, ZHAO Yi, TAO Qian, HAN Xin-guang, LI Jin-song, SU Tong, LI Bo, ZHANG Lei, HU Yan-ping, CHEN Chuan-jun, LI Yi, LI Tie-jun, ZHAO Yi-fang China Journal of Oral and Maxillofacial Surgery    2022, 20 (3): 209-218.   DOI: 10.19438/j.cjoms.2022.03.001 Abstract （1951）      PDF （1176KB）（916）       Knowledge map    Odontogenic keratocyst (OKC) is a common cystic lesion of the jaw. The nomenclature and nature of OKC remain controversial as a result of its local invasive behavior and high tendency of recurrence, which is evidently different from other types of jaw cysts. With the in-depth study of OKC pathogenesis and the advance of treatment concept and surgical techniques, it becomes possible to reduce the rate of postoperative recurrence and simultaneous functional reconstruction of the jaw. To establish standard diagnosis and treatment algorithms or guidelines of OKC, we organized peer experts in China to reach a consensus on pathogenesis, clinical manifestations, imaging characteristics, histopathological features, surgery and postoperative follow-up strategies of OKC for the references of clinicians. Reference | Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2006, 4 (6): 467-470.   Abstract （1940）      PDF （747KB）（1303）       Knowledge map    Related Articles | Metrics

Select

Clinical application of Tent-Peg technique in the reparation and regeneration of alveolar bone-standard operational practice ZOU Duo-hong, LIU Chang-kui, XUE Yang, HU Kai-jin, YANG Chi, ZHNAG Zhi-yuan China Journal of Oral and Maxillofacial Surgery    2021, 19 (1): 1-5.   DOI: 10.19438/j.cjoms.2021.01.001 Abstract （2248）      PDF （3998KB）（1552）       Knowledge map    ] Alveolar bone is the foundation of dentology. The reparation and regeneration of alveolar bone defects have strong relationship with sub-disciplines including implant dentistry, orthodontics, periodontology and prosthodontics. Therefore, the effective methods of repairing and reconstructing alveolar bone have important clinical significance and great social benefits. With the development of guide bone regeneration (GBR) technique and advent of alveolar bone regeneration based on stability centered concept, an entirely new bone augmentation approach based on Tent-Peg technique developed rapidly and was validated in clinical practices. The technique is characterized by low technique sensitivity, simple operation procedure, short operation time and low costs. Furthermore, alveolar bone regeneration based on this technique can be achieved with just artificial biomaterials instead of autogenous bone grafts. In conjunction with its advantages, Tent-Peg technique is increasingly favored and valued by patients and clinicians. However, clinicians still face many difficulties achieving effectively clinical application of this technique, including standard operation practice, right position of the Tent-Peg, proper orientation of the pegs and right order of placing GBR membrane and Tent-Peg. Our team established standard operation practice of Tent-Peg technique for alveolar bone regeneration based on clinical practice. We hope that this article will provide a reference and basis for clinicians when applying this technique for alveolar bone regeneration, popularize the clinical application of this technique and finally offer practical help to patients suffering from alveolar bone defects. Reference | Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2009, 7 (2): 168-175.   Abstract （561）      PDF （1607KB）（1915）       Knowledge map    Related Articles | Metrics

Select

Evaluation of the application of double wire anchor nails in temporomandibular joint disc anchorage WUERGULI Alifu, REYILAI Abudukeremu, LIU Jiang-long, MAIMAITITUXUN Tuerdi China Journal of Oral and Maxillofacial Surgery    2023, 21 (4): 397-402.   DOI: 10.19438/j.cjoms.2023.04.013 Abstract （347）      PDF （1789KB）（403）       Knowledge map    PURPOSE: To evaluate the clinical efficacy of double wire anchorage in the treatment of temporomandibular joint disc anterior displacement. METHODS: Thirty patients with anterior disc displacement without reduction(ADDWoR) diagnosed in First Affiliated Hospital of Xinjiang Medical University from June 2021 to February 2022 were included to fix the discs with double wire anchors. The maximal open mouth, visual analogue scale (VAS) scores of the patients before and at different time periods were analyzed, the patients' self-satisfaction was recorded, and the length of MRI discs and condylar height before and after operation were measured. SPSS 25.0 software was used to analyze the data and evaluate the surgical results. RESULTS: The mean age was 24.43±8.87 years old, the mean mouth opening before operation was (29.17±5.38) mm (19-42 mm), the mean maximum mouth opening after operation was (39.17±2.57) mm (35-45 mm), and 93.3% of the patients after operation had the maximum mouth opening >35 mm; the mean VAS before operation was 58.33±21.19 (10-90), the mean VAS 6 months after operation was 11.67±6.99(0-20), the mouth opening and the value of VAS 6 months after operation had significant difference compared with prior to operation(P<0.05). The disc length was (9.77±0.63), (11.96±0.68) and (12.72±0.55) mm preoperatively, immediately postoperatively and 6 months after surgery. The condyle height increased by (1.08±0.61) mm 6 months after surgery compared with immediately postoperatively (P<0.05). CONCLUSIONS: Double wire anchorage in the reduction and anchorage of TMJ disc can improve the mouth opening, relieve pain, increase the length of TMJ disc and increase the height of condyle. Reference | Related Articles | Metrics

Select

Interpretation of the new TNM classification and the NCCN guidelines for cancers of the oral cavity and oropharynx SHANG Wei, ZHENG Jia-wei China Journal of Oral and Maxillofacial Surgery    2018, 16 (6): 533-546.   DOI: 10.19438/j.cjoms.2018.06.010 Abstract （2156）      PDF （9751KB）（768）       Knowledge map    The AJCC Cancer Staging Manual and the NCCN Clinical Practice Guidelines in Oncology are widely used in clinical practice. NCCN diagnosis and treatment guidelines are closely related to TNM staging, and the guidelines provide more detailed diagnostic and therapeutic criteria for cancers with different TNM staging as a basis for guiding clinical application. The 8th edition TNM staging system for cancers of the oral cavity and oropharynx introduced a number of significant changes, such as depth of invasion(DOI), extranodal extension (ENE), human papillomavirus(HPV) and other indicators were used in the new stage, and a new chapter describing the staging of HPV-associated oropharyngeal cancers had been added. The 2018 NCCN guidelines for cancers of the oral cavity and oropharynx timely reflected the new changes in the 8th edition TNM staging, and the panel also created separate algorithms for HPV-associated (p16-positive) oropharyngeal cancer. The new TNM staging and NCCN guidelines are of great guiding significance in the treatment strategies and plans for patients with cancers of the oral cavity and oropharynx. The treatment recommendations were provided and the interpretation was made for the needs of clinical practice in this paper. Reference | Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2005, 3 (3): 202-206.   Abstract （862）      PDF （2707KB）（667）       Knowledge map    Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2003, 1 (2): 74-77.   Abstract （1865）      PDF （766KB）（3760）       Knowledge map    Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2005, 3 (2): 139-141.   Abstract （2052）      PDF （556KB）（813）       Knowledge map    Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2010, 8 (2): 123-129.   Abstract （837）      PDF （1218KB）（756）       Knowledge map    Related Articles | Metrics

Select

Familial gigantiform cementoma: analysis of a large Chinese pedigree WANG Hong-wei, YU Miao, QIN Xing-jun, WANG Li-zhen, XU Li-qun, ZHANG Chen-ping China Journal of Oral and Maxillofacial Surgery    2014, 12 (4): 360-364.   Abstract （495）   HTML （3）    PDF （1571KB）（1233）       Knowledge map    PURPOSE: Familial gigantiform cementoma (FGC) is a rare autosomal dominant benign odontogenic tumor. The purpose of this study is to describe the clinical characteristics of FGC in a Chinese family with multiple-affected members. METHODS: Detail screening was conducted on family members of a 13-year-old Chinese male with recent diagnosis of FGC. All family members of the patient were interviewed. Demographic, past medical and surgical histories were collected from family members with history of FGC diagnosis. Clinical information related to the lesions (symptom, age of onset, history of treatment, histological and radiological findings) was obtained. Literature review was also presented in this study. RESULTS: In this study, we found a four-generation Han Chinese family with thirteen affected members with diagnosis of FGC. Eight male patients and five female patients were appreciated in the study. All 13 patients experienced the onset of symptoms at 11-13 years old followed by a rapid and expansive growth phrase at the age of 14-16, and growth suppression phase around age 18 to 20 years old. Eight patients in our series had sustained multiple pathological long bone fractures (average 3-4 x/person) between the age of 13 and 16 years. CONCLUSIONS: The familial history of this case helps to demonstrate that the inheritance pattern of FGC was autosomal dominant. FGC usually presented with three distinctive growth phrases: ①Initial onset; ②Rapid expansion; ③Growth suppression phase. Reference | Related Articles | Metrics

Select

Overview of current pharmacotherapy for infantile hemangiomas ZHENG Jia-wei, MA Kun-ning, ZHANG Ling China Journal of Oral and Maxillofacial Surgery    2014, 12 (1): 1-6.   Abstract （538）   HTML （5）    PDF （893KB）（927）       Knowledge map    Infantile hemangiomas (IH) are the most common tumors of infancy and childhood. 60% of them are localized in the head and neck region. They may impinge on vital structures, ulcerate, bleed, cause high-output cardiac failure or significant disfigurement if left untreated. The traditional treatment methods include drug therapy, laser therapy and surgery, with drug therapy being the mainstay of treatment. The medications most commonly used to treat IH are corticosteroids, beta-adrenergic blocker, pingyangmycin, interferon alfa, imiquimod, and etc. For function- and life-threatening infantile hemangioma, some anti-cancer agents like vincristine may be used as an effective alternative option. This succinct review summarized current pharmacotherapeutic therpy of IH, especially the properties and effectiveness of various beta-adrenergic antagonists in the management of IH. Reference | Related Articles | Metrics

Select

China Journal of Oral and Maxillofacial Surgery    2012, 10 (6): 516-521.   Abstract （583）      PDF （783KB）（1533）       Knowledge map    Related Articles | Metrics